Dagher M, Ongo G, Robichaud N, et al. nELISA: A high-throughput, high-plex platform enables quantitative profiling of the inflammatory secretome. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2023.04.17.535914
Center for the Development of Therapeutics
Haj AK, Paul DS, Jurgens SJ, et al. Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis. Nature communications. 2025;16(1):8176. doi:10.1038/s41467-025-62789-5
Shaw S, Jiang W, Rush J, et al. Identification of small molecule inhibitors of PPM1D using an integrated drug discovery platform. iScience. 2025;28(3):112069. doi:10.1016/j.isci.2025.112069
Ewald JD, Titterton KL, Bäuerle A, et al. Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.01.22.634152
Kabi M, Khamamkar A, Kyei-Baffour K, Weïwer M, Vijayaraghavan S, Dey S. A non-hormonal reversible contraceptive targeting GSK3α, a protein kinase, essential for epididymal sperm maturation. Andrology. 2025. doi:10.1111/andr.13838
Rauh U, Wei G, Serrano-Wu M, et al. BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models. Nature cancer. 2024. doi:10.1038/s43018-024-00814-0
Arbesfeld JA, Da EY, Stevenson JS, et al. Mapping MAVE data for use in human genomics applications. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2023.06.20.545702
Chandrasekaran SN, Cimini BA, Goodale A, et al. Three million images and morphological profiles of cells treated with matched chemical and genetic perturbations. Nature methods. 2024. doi:10.1038/s41592-024-02241-6
Rubinson DA, Tanaka N, de la Cruz FF, et al. Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers. Cancer discovery. 2024;14(5):727-736. doi:10.1158/2159-8290.CD-23-1138
Zerbib J, Ippolito MR, Eliezer Y, et al. Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage. Nature communications. 2024;15(1):7772. doi:10.1038/s41467-024-52176-x